Pharma/Life Sciences
Europe Guide 2024 : France
Band 2
Email address
[email protected]Contact number
+33 1 40 06 54 00Chambers Review
The firm has a well-regarded team frequently advising pharmaceutical companies and medical device manufacturers on a broad range of IP and regulatory matters. The team acts on patent infringements and nullity actions, as well as representing clients in litigation relating to pharmaceutical treatments. The law firm also assists with regulations related to medical products and life sciences projects. The lawyers are well versed in cross-border matters concerning a variety of European jurisdictions. On 1st May 2024, Allen & Overy and Shearman & Sterling merged to form A&O Shearman.
Work Highlights
- The firm advised Ipsen on its entry into exclusive negotiations with Mayoly Spindler regarding the divestment of its consumer healthcare business.
Notable Practitioners
Laëtitia Bénard remains a key name in the market and is recognised for her expertise in domestic and multi-jurisdictional patent litigations. She represents leading global pharmaceutical companies in proceedings at the French and European level.
"Laëtitia is well-versed in patent cases within the pharma sector; she is undoubtedly extremely knowledgeable."